1. Gilead’s Kite files for FDA approval of second CAR-T — Merck’s Keytruda gets win for triple-negative breast cancer — The House votes on the Lower Drug Cost Now Act — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Time To Move On

Discussion in 'Ista Pharma' started by Anonymous, Jun 26, 2012 at 8:20 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    I guess those of us that are left should start posting to the B&L board now. It was a good ride. I enjoyed it. I'll miss seeing many of you at the corporate meeting. Good luck.
     

  2. Anonymous

    Anonymous Guest

    They are not telling us anything as far as the truth. I want to know how many of us will actually keep our jobs